<VariationArchive VariationID="1076796" VariationName="NM_001029.5(RPS26):c.9_12del (p.Lys4fs)" VariationType="Deletion" Accession="VCV001076796" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-15" DateCreated="2021-05-10" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1062686" VariationID="1076796">
      <GeneList>
        <Gene Symbol="RPS26" FullName="ribosomal protein S26" GeneID="6231" HGNC_ID="HGNC:10414" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="56041918" stop="56044697" display_start="56041918" display_stop="56044697" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="56435685" stop="56438006" display_start="56435685" display_stop="56438006" Strand="+" />
          </Location>
          <OMIM>603701</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS26">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS26">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001029.5(RPS26):c.9_12del (p.Lys4fs)</Name>
      <CanonicalSPDI>NC_000012.12:56042426:AAAGAAA:AAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="56436211" stop="56436214" display_start="56436211" display_stop="56436214" variantLength="4" positionVCF="56436210" referenceAlleleVCF="CAAAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="56042427" stop="56042430" display_start="56042427" display_stop="56042430" variantLength="4" positionVCF="56042426" referenceAlleleVCF="CAAAG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K4fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.56436214_56436217del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.56436214_56436217del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.56042430_56042433del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.56042430_56042433del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023201.1" sequenceAccession="NG_023201" sequenceVersion="1" change="g.5529_5532del">
            <Expression>NG_023201.1:g.5529_5532del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001029.5" sequenceAccession="NM_001029" sequenceVersion="5" change="c.9_12del" MANESelect="true">
            <Expression>NM_001029.5:c.9_12del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001020.2" sequenceAccession="NP_001020" sequenceVersion="2" change="p.Lys4fs">
            <Expression>NP_001020.2:p.Lys4fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1146" sequenceAccession="LRG_1146">
            <Expression>LRG_1146:g.5529_5532del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1146t1" sequenceAccession="LRG_1146t1">
            <Expression>LRG_1146t1:c.9_12del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1146p1" sequenceAccession="LRG_1146p1" change="p.Lys4fs">
            <Expression>LRG_1146p1:p.Lys4fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2136753785" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001029.5(RPS26):c.9_12del (p.Lys4fs) AND Diamond-Blackfan anemia 10" Accession="RCV001390815" Version="7">
        <ClassifiedConditionList TraitSetID="1693">
          <ClassifiedCondition DB="MedGen" ID="C2750080">Diamond-Blackfan anemia 10</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-01-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001029.5(RPS26):c.9_12del (p.Lys4fs) AND Diamond-Blackfan anemia" Accession="RCV002377582" Version="3">
        <ClassifiedConditionList TraitSetID="1756">
          <ClassifiedCondition DB="MedGen" ID="C1260899">Diamond-Blackfan anemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-03-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-22" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-10" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20116044</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22381658</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23718193</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28102861</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1693" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6691" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Diamond-Blackfan anemia 10</ElementValue>
                <XRef ID="MONDO:0013217" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DBA10</ElementValue>
                <XRef Type="MIM" ID="613309" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Diamond-Blackfan anemia (DBA) is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50%, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia or no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.</Attribute>
                <XRef ID="NBK7047" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15645" />
                <XRef ID="15645" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301769</ID>
                <ID Source="BookShelf">NBK7047</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083626</ID>
              </Citation>
              <XRef ID="124" DB="Orphanet" />
              <XRef ID="C2750080" DB="MedGen" />
              <XRef ID="MONDO:0013217" DB="MONDO" />
              <XRef Type="MIM" ID="613309" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1756" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1485" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Diamond-Blackfan anemia</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
                <XRef ID="88854002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Blackfan Diamond syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anemia congenital erythroid hypoplastic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aregenerative anemia chronic congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Erythrogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Red cell aplasia, pure hereditary</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital hypoplastic anemia</ElementValue>
                <XRef ID="HP:0004810" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aase syndrome</ElementValue>
                <XRef ID="MONDO:0015253" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DBA</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BDS</ElementValue>
                <XRef Type="MIM" ID="105650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6274" />
                <XRef ID="6274" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Diamond-Blackfan anemia (DBA) is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50%, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia or no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.</Attribute>
                <XRef ID="NBK7047" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301769</ID>
                <ID Source="BookShelf">NBK7047</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083626</ID>
              </Citation>
              <XRef ID="124" DB="Orphanet" />
              <XRef ID="C1260899" DB="MedGen" />
              <XRef ID="D029503" DB="MeSH" />
              <XRef ID="MONDO:0015253" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS105650" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004810" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005545" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7159973" SubmissionDate="2023-02-19" DateLastUpdated="2023-03-11" DateCreated="2023-03-11">
        <ClinVarSubmissionID localKey="17441|OMIM:613309" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003836127" DateUpdated="2023-03-11" DateCreated="2023-03-11" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001029.5:c.9_12del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613309" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12876118</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3118349" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4907381|MedGen:C2750080" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001592663" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28102861</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20116044</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23718193</ID>
          </Citation>
          <Comment>This variant has been observed in individual(s) with Diamond‚ÄìBlackfan anemia (DBA) (PMID: 28102861). This variant is also known as c.6_9delAAAG in the literature. ClinVar contains an entry for this variant (Variation ID: 1076796). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Lys4Glufs*40) in the RPS26 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPS26 are known to be pathogenic (PMID: 20116044, 23718193). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS26" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.56436211_56436214del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2750080" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5170293" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a80308|MedGen:C1260899" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002685063" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22381658</ID>
          </Citation>
          <Comment>The c.9_12delGAAA pathogenic mutation, located in coding exon 2 of the RPS26 gene, results from a deletion of 4 nucleotides at nucleotide positions 9 to 12, causing a translational frameshift with a predicted alternate stop codon (p.K4Efs*40). This mutation was identified in one Czech individual with Diamond-Blackfan anemia (Pospisilova D et al. Blood Cells Mol. Dis., 2012 Apr;48:209-18). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS26" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001029.3:c.9_12delGAAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1260899" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5170293" TraitType="Disease" MappingType="XRef" MappingValue="C1260899" MappingRef="MedGen">
        <MedGen CUI="C1260899" Name="Diamond-Blackfan anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7159973" TraitType="Disease" MappingType="XRef" MappingValue="613309" MappingRef="OMIM">
        <MedGen CUI="C2750080" Name="Diamond-Blackfan anemia 10" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3118349" TraitType="Disease" MappingType="XRef" MappingValue="C2750080" MappingRef="MedGen">
        <MedGen CUI="C2750080" Name="Diamond-Blackfan anemia 10" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

